You are here: Home » News-IANS » Health-Medicine
Business Standard

New mechanism that may prevent Alzheimer's identified

Topics
Health Medical Pharma

IANS  |  New York 

Researchers have identified a novel mechanism and a potential new therapeutic target for Alzheimer's disease (AD), says a new study on mice.

Alzheimer's is characterised by profound memory loss and synaptic failure. Although the exact cause of the disease remains unclear, it is well established that maintaining memory and synaptic plasticity requires protein synthesis.

The function of the synapse is to transfer electric activity (information) from one cell to another.

"Alzheimer's is such a devastating disease and currently there is no cure or effective therapy for it," said Tao Ma, Assistant Professor at Wake Forest School of Medicine in the US.

"All completed clinical trials of new drugs have failed, so there is clearly a need for novel therapeutic targets for potential treatments."

For the study, the team has shown that AD-associated activation of a signaling molecule termed eEF2K leads to inhibition of protein synthesis.

Further, they wanted to determine if suppression of eEF2K could improve protein synthesis capacity, consequently alleviating the cognitive and synaptic impairments associated with the disease.

They used a genetic approach to repress the activity of eEF2K in Alzheimer's mouse models.

The findings, published in the Journal of Clinical Investigation, showed that genetic suppression of eEF2K prevented memory loss in those animal models and significantly improved synaptic function.

"These findings are encouraging and provide a new pathway for further research," said Ma.

The team next plans to test this approach in additional animal studies and eventually in human trials using small molecule inhibitors targeting eEF2K.

--IANS

pb/rtp/ab

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, February 12 2019. 15:44 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU